Ovarian biomarkers predict controlled ovarian stimulation for in vitro fertilisation treatment in Singapore

Simplified 4-item criteria for polycystic ovary syndrome: A bridge too far?

(2018) Inthrani R. Indran et al.   CLINICAL ENDOCRINOLOGY

Non-equivalence of anti-Müllerian hormone automated assays—clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing

(2017) Stamatina Iliodromiti et al.   HUMAN REPRODUCTION

Age-related nomograms for antral follicle count and anti-Mullerian hormone for subfertile Chinese women in Singapore

(2017) See Ling Loy et al.   PLoS One

Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome

(2014) David E. Reichman et al.   FERTILITY AND STERILITY

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles

(2014) Ryan G. Steward et al.   FERTILITY AND STERILITY

Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay

(2014) X. Han et al.   HUMAN REPRODUCTION

The physiology and clinical utility of anti-Müllerian hormone in women

(2014) Didier Dewailly et al.   HUMAN REPRODUCTION UPDATE

GnRH agonist trigger and ovarian hyperstimulation syndrome: relook at ‘freeze-all strategy’

(2014) Liza Ping Ling et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis

(2013) Simone L. Broer et al.   FERTILITY AND STERILITY

Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization

(2013) Antonio La Marca et al.   FERTILITY AND STERILITY

Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice

(2013) A. La Marca et al.   HUMAN REPRODUCTION UPDATE

Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH

(2013) Vuong Thi Ngoc Lan et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach

(2012) Simone L. Broer et al.   HUMAN REPRODUCTION UPDATE

Correlation between three assay systems for anti-Müllerian hormone (AMH) determination

(2012) Hang Wun Raymond Li et al.   JOURNAL OF ASSISTED REPRODUCTION AND GENETICS

Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles

(2011) Sesh Kamal Sunkara et al.   HUMAN REPRODUCTION

Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American women

(2011) S. M. Schuh-Huerta et al.   HUMAN REPRODUCTION

ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria

(2011) A. P. Ferraretti et al.   HUMAN REPRODUCTION

GnRH agonist for triggering of final oocyte maturation: time for a change of practice?

(2011) P. Humaidan et al.   HUMAN REPRODUCTION UPDATE

The journey from the old to the new AMH assay: how to avoid getting lost in the values

(2011) S.M. Nelson et al.   REPRODUCTIVE BIOMEDICINE ONLINE

AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis

(2010) S. L. Broer et al.   HUMAN REPRODUCTION UPDATE

Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts

(2009) J. van Disseldorp et al.   HUMAN REPRODUCTION

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count

(2008) Simone L. Broer et al.   FERTILITY AND STERILITY

Variations in serum müllerian inhibiting substance between white, black, and Hispanic women

(2008) David B. Seifer et al.   FERTILITY AND STERILITY